Market Summary | Major Indices | Market Movers | Market Sectors | Mutual Funds | A-Z Stock Listings
ETF Screener | World Markets | Currencies | CEO Wealthmeter | Oil / Energy | Metals
Treasury Rates | Calculators | My Watchlist | My Portfolio
         Symbol Lookup
ICAGEN Add to My Watchlist (NSDQ: ICGN) 
Detailed Quote
News
Chart
SEC Filings
Profile
Historical
Options
     Icagen 0.76 -0.03 (-3.77%) 46,391
4222 Emperor Boulevard
Suite 350
Durham, NC 27703 US
(919) 941-5206
(919) 941-0813 fax
www.icagen.com
CEO Dr. P. Kay Wagoner, Ph.D.
Auditor Ernst & Young LLP
Exchange Traded NQ
ISIN Number US45104P1049
CIK Number 902622
NAICS Code 325412
Business Summary
A biopharmaceutical company focused on the discovery, development and commercialization of novel orally-administered small molecule drugs that modulate ion channel targets.
Number of Employees 70
Share Fundamentals
Market Cap 35.86M
Shares Outstanding 47.18M
Float 45.86M
Short Interest 22.48K
Financial Strength
Revenue (TTM) $11,266,000
Earnings (TTM) -$13,381,000
Quick Ratio 5.5:1
Current Ratio 5.7:1
Total Debt/Equity 0.05:1
Profitability
Gross Margin N/A
EBITDA Margin N/A
Profit Margin N/A
Powered By: FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes.
All other data is delayed at least 20 minutes.
By accessing this page, you agree to the following terms and conditions.
Stock News provided by MarketMinute.com
Stock Analysis provided by SocialPicks Conference calls info supplied by OpenCompany
Fundamental data supplied by Mergent, Inc.
Stock quote data supplied by Telekurs